TGF-beta3: A promising growth factor in engineered organogenesis

Area of Science:

• Regenerative Medicine
• Developmental Biology
• Biotechnology

Background:

• Engineered organogenesis is a complex frontier in regenerative medicine.
• Growth factors are crucial for tissue regeneration, influencing cell behavior.
• Transforming growth factor-beta3 (TGF-beta3) is a key player with diverse cellular effects.

Purpose of the Study:

• To review the role of TGF-beta3 in engineered osteogenesis, chondrogenesis, palate development, scar-free wound healing, odontogenesis, and neurogenesis.
• To understand the current applications of TGF-beta3 in regenerative medicine.
• To highlight TGF-beta3's potential in tissue engineering.

Main Methods:

• Systematic review of existing literature.
• Analysis of studies employing TGF-beta3 in organogenesis.
• Focus on engineering methodologies and regenerative medicine perspectives.

Main Results:

• TGF-beta3 demonstrates efficacy as a growth factor in in vitro engineered organogenesis.
• Recent in vivo studies show significant therapeutic success in animal models.
• TGF-beta3 is a promising candidate for future clinical applications.

Conclusions:

• TGF-beta3 is a competent factor for engineered organogenesis.
• In vivo applications of TGF-beta3 show considerable therapeutic potential.
• Further research supports TGF-beta3's translation to human therapies.